Nasdaq GlobeNewswire

AccessData Launches AD RTK(TM), New Tool to Identify and Remediate Problematic Data Across Enterprise Networks

Del

Powered by AccessData's industry-leading forensics software, new product identifies potential information risks to organizations

LINDON, Utah, Nov. 14, 2017 (GLOBE NEWSWIRE) -- AccessData Group, a leading provider of integrated digital forensics and e-discovery software, today announced the launch of AD RTK(TM) (Risk Toolkit), a powerful new tool corporations and government agencies can use to combat problematic or sensitive data.

The tool locates potential information risks -- very often, authorized data residing in unauthorized locations, such as classified information on an unclassified network -- and remediates it across the enterprise.

"Faced with new regulations and heightened scrutiny around data protection, organizational leaders need complete visibility into where their sensitive data resides across the enterprise so they can secure important data in appropriate repositories," said Victor Limongelli, chief executive officer of AccessData. "AD RTK leverages our proven enterprise search and investigative forensics capabilities to find and eliminate data that should not exist, or should exist only in defined locations."

AD RTK is operated from a very simple user interface, which means that technical and non-technical teams alike can act quickly to initiate a first-pass scan, flag potentially problematic data and take immediate action to remediate or destroy the risk. This enables all teams across an organization - such as HR, Legal and Compliance -- to take a more pro-active role in helping to protect the company's sensitive data and reduce the risk of data loss and potential breach. The tool also functions as a more easily deployed and more affordable solution for organizations that lack the IT budget for an expensive data loss prevention software product.

The primary examples of common information risks residing on enterprise IT networks unbeknownst to the organization's leadership include improperly retained Personally Identifiable Information (PII), such as credit card numbers, Protected Health Information (PHI), classified data (for Federal agencies or suppliers), and unapproved software applications stored on the network. In addition, the new General Data Protection Regulation (GDPR) that goes into effect across the European Union in May 2018 identifies strict guidelines for how personal data can be processed, shared and stored by organizations.

AD RTK can run scans of thousands of computer endpoints and network share repositories once at a time or it can be scheduled for recurring jobs to ensure ongoing vigilance.

"AD RTK locates data, assesses compliance risk and gives users the opportunity to delete offending files," said Limongelli. "It is a powerful tool for fast, pro-active data risk mitigation. If the discovery of a potential risk leads to a determination there is a need to launch a full-scale forensics investigation, users can leverage AD Enterprise, our robust platform for managing large forensic investigations."

For more information about AD RTK, please click here.

About AccessData

Whether it's for investigation, litigation or compliance, AccessData® offers industry-leading solutions that put the power of forensics in your hands.  For 30 years, AccessData has worked with more than 130,000 customers in law enforcement, government agencies, corporations and law firms around the world, providing both stand-alone and enterprise-class solutions that can synergistically work together. The company is backed by Sorenson Capital, a leading private equity firm focused on high-growth portfolios. For more information on AccessData, please go to www.accessdata.com

Media Contact:
Lori Tyler
Vice President, Marketing
ltyler@accessdata.com 



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: AccessData via Globenewswire

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

GlobeNewswire Test Release26.5.2018 07:00Pressemelding

LOS ANGELES, May 25, 2018 (GLOBE NEWSWIRE) -- This is a test from GlobeNewswire. Readers are advised to disregard. TESTING -- TESTING -- TESTING -- TESTING -- TESTING -- TESTING -- TESTING -- TESTING – -END- CONTACT: Karen Yu Director, GlobeNewswire Product Management Direct: +1 310 258 6917 Mobile: +1 626 389 7427 or Magali Rolandez Senior Manager, Media Relations/Content Distribution Europe Direct: +44 (0) 203 753 2215 Mobile: +44 (0) 7785 619 539

Medibio Corporate Health Extends Global Footprint Signing Contract with Jacobs Engineering25.5.2018 16:38Pressemelding

Jacobs, one of the world's largest engineering and environmental consultancy groups, has more than 70,000 employees globally SYDNEY, Australia and MINNEAPOLIS, May 25, 2018 (GLOBE NEWSWIRE) -- Medibio Limited (MEB or the Company) (ASX:MEB) (OTCQB:MDBIF), a mental health technology company, today announced a significant contract for Medibio's Corporate Health product with Dallas, TX-based Jacobs Engineering across their Asia Pacific, Middle East, and European divisions. Through the Mental Health Check-In, companies can offer employees an end-to-end mental health program, direct to their devices, to see how the mind and body are tracking. It's a personalized, private, and objective way to see the unseeable: mental health issues in the workplace. Employees are provided the opportunity to confidentially check-in on their mental health and receive personalized confidential results from both an objective biometric screening in conjunction with a 12-minute subjective survey. Employers receive

VIRGIN PULSE ANNOUNCES INDUSTRY-LEADING GDPR COMPLIANCE25.5.2018 14:00Pressemelding

Virgin Pulse Extends the GDPR's Strong Data Privacy Rights to All Clients and Members Across the Globe PROVIDENCE, R.I., May 25, 2018 (GLOBE NEWSWIRE) -- Virgin Pulse, the leading global provider of digital employee health, wellbeing and engagement solutions, today announced that it has achieved compliance with the EU General Data Protection Regulation (GDPR) for the Virgin Pulse platform. The company has also appointed Associate Counsel Beatrice Botti as Data Protection Officer (DPO) to oversee the Virgin Pulse privacy program. With this achievement, Virgin Pulse leads the market as the first company in the wellbeing and engagement industry to fully meet the comprehensive standards of the new GDPR data privacy law. The company has completed a thorough review of its internal data collection, storage and handling processes and implemented enhancements to achieve GDPR compliance and give all Virgin Pulse customers and members greater control over their personal data. The GDPR is the firs

Resverlogix Provides Unrestricted Educational Grant for Epigenetic Symposium at International Renal Congress25.5.2018 07:45Pressemelding

CALGARY, Alberta, May 24, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) today announced that on Friday, May 25, 2018, at the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Congress in Copenhagen, Denmark, the Company is supporting a symposium titled: "Epigenetics in CKD & CVD: A potential breakthrough therapy?" The symposium highlights the role of epigenetics and BET-inhibition in chronic kidney disease and cardiovascular disease, especially in patients with diabetes mellitus, and the significant unmet need that still exists in this patient population. The symposium is co-chaired by Vincent M. Brandenburg, MD - Nephrologist, Aachen, Germany and Kamyar Kalantar-Zadeh, MD - UC Irvine School of Medicine, Irvine, CA, USA, both leading scientists also serving as advisors to Resverlogix's Renal program. The speakers and agenda are as follows: Introduction Vincent M. Brandenburg, MD - University Hospital of the RWTH

Atico Reports Consolidated Financial Results for the First Quarter of 201824.5.2018 22:30Pressemelding

(All amounts expressed in US dollars, unless otherwise stated) VANCOUVER, British Columbia, May 24, 2018 (GLOBE NEWSWIRE) -- Atico Mining Corporation (the "Company" or "Atico") (TSX.V:ATY) (OTC:ATCMF) today announced its financial results for the three months ended March 31, 2018, posting a net income of $0.4 million. Fernando E. Ganoza, CEO and Director, commented, "The strong production and all-in sustaining cash cost of $1.85 achieved this quarter is not reflected in the financial results as a large concentrate shipment was delayed to the second quarter, along with the revenue associated with those tonnes. The shipping schedule is expected to stabilize during the second quarter, where we will then benefit from the additional shipped concentrate and recognized revenue. We anticipate strong financial results in the next quarter." Mr. Ganoza continued, "Our emphasis will continue to be on further strengthening our balance sheet, improving production costs and most importantly regional

Luxembourg Announced as SNOMED International's Newest Member24.5.2018 15:16Pressemelding

London, United Kingdom, May 24, 2018 (GLOBE NEWSWIRE) -- SNOMED International and Agence eSanté Luxembourg are pleased to announce that Luxembourg has joined the organization as its thirty-second Member. Luxembourg, one of the leading nations in the area of information and communication technology, has set the development of eHealth technologies as a high priority. Agence eSanté, Luxembourg's national agency for the exchange and sharing of medical data, has set an overall mission to facilitate clinical information exchange both within Luxembourg and across other international actors. To work towards this reality, the agency has taken part in discussions about standardization across Europe, a contributing building block achieved with its membership in SNOMED International. With their membership, Agence eSanté has committed their support for the use of structured clinical terminology. When applied to the health sector, interoperability ensures that information systems, and through them h

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom